Hudson Frederick M.

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hudson Frederick M.'s trades of Supernus Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-12
S Sale
12,808 -31.3%
345.46
US$3,953,014 		12,808 -31.3% 345.46 US$3,953,014
2026-03-12 2026-03-12
PrS Proposed sale
9,407
49.88
US$2,395,260 		9,407 49.88 US$2,395,260
2025-08-18 2025-08-14
S Sale
70,963 +6.2%
373.35
US$4,007,596 		70,963 +6.2% 373.35 US$4,007,596
2025-08-14 2025-08-14
PrS Proposed sale
7,457
42.26
US$315,116 		7,457 42.26 US$315,116
2024-11-12 2024-11-08
S Sale
8,722 -23.5%
36.28
US$316,434 		8,722 -23.5% 36.28 US$316,434
2024-11-08 2024-11-08
PrS Proposed sale
8,722
36.28
US$316,476 		8,722 36.28 US$316,476
2023-11-17 2023-11-15
S Sale
5,211 -13.6%
28.50
US$148,514 		5,211 -13.6% 28.50 US$148,514
2023-11-17 2023-11-15
S Sale
3,882 -9.2%
28.50
US$110,637 		3,882 -9.2% 28.50 US$110,637
2023-11-15 2023-11-15
PrS Proposed sale
3,882
28.50
US$110,655 		3,882 28.50 US$110,655
2023-11-14 2023-11-14
PrS Proposed sale
5,211
28.16
US$146,741 		5,211 28.16 US$146,741
2020-07-15 2020-07-13
PlS Planned sale
920 -4.9%
24.44
US$22,485 		920 -4.9% 24.44 US$22,485